Exhaled Nitric Oxide in healthy children 1 - 4 years old

Recruiting

• Conditions: asthma; astma; 10024967

• Registration Number: NL-OMON32593
• Lead Sponsor: Canisius Wilhelmina Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Healthy children aged 12 - 48 months (1 - 4 years old)

Exclusion Criteria

- Medical history of: asthma, viral wheeze, eczema, allergic rhinitis or other allergies/pulmonary diseases
- An active upper or lower respiratory tract infection during the eNO-measurement
- Medication: β2-sympathicomimetics, inhalation corticosteroids, leukotriene receptor antagonists or antihistamines

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>exhaled NO (in parts per billion)<br /><br>The mean eNO concentration, the standard deviation and the 95% reference<br /><br>interval (RI) for the eNO will be calculated. The 95% reference interval will<br /><br>be considered as reference values. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>